Tetsuhiro Soeda

Researcher
Chugai Pharmaceutical Co., Ltd.

Presentation(s):

• VPB0171 - The effect of anti-coagulant agents against in vitro hemophilia A plasma coagulation and fibrinolysis potential in the presence of emicizumab

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM

• VPB0206 - Characterization of Anti-Emicizumab Antibodies Using Repository Samples Obtained in Clinical Studies of Emicizumab Conducted in Japan

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM

• VPB0208 - Coagulant potential of emicizumab in child hemophilia A patients

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM